A detailed history of Well Done, LLC transactions in Amgen Inc stock. As of the latest transaction made, Well Done, LLC holds 1,442 shares of AMGN stock, worth $479,392. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,442
Previous 2,424 40.51%
Holding current value
$479,392
Previous $689,000 34.69%
% of portfolio
0.09%
Previous 0.14%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$262.75 - $319.31 $258,020 - $313,562
-982 Reduced 40.51%
1,442 $450,000
Q1 2024

Apr 18, 2024

BUY
$268.87 - $324.56 $32,264 - $38,947
120 Added 5.21%
2,424 $689,000
Q4 2023

Jan 18, 2024

BUY
$255.7 - $288.46 $7,926 - $8,942
31 Added 1.36%
2,304 $663,000
Q3 2023

Oct 16, 2023

SELL
$218.65 - $271.46 $1,530 - $1,900
-7 Reduced 0.31%
2,273 $610,000
Q2 2023

Jul 20, 2023

SELL
$214.27 - $253.37 $67,495 - $79,811
-315 Reduced 12.14%
2,280 $506,000
Q1 2023

Apr 20, 2023

BUY
$225.79 - $275.2 $25,288 - $30,822
112 Added 4.51%
2,595 $627,000
Q4 2022

Jan 17, 2023

BUY
$229.03 - $291.01 $19,009 - $24,153
83 Added 3.46%
2,483 $0
Q3 2022

Oct 14, 2022

BUY
$224.46 - $253.15 $28,281 - $31,896
126 Added 5.54%
2,400 $541,000
Q4 2021

Jan 21, 2022

SELL
$198.88 - $227.6 $4,972 - $5,690
-25 Reduced 1.09%
2,274 $512,000
Q3 2021

Nov 01, 2021

BUY
$212.27 - $248.7 $849 - $994
4 Added 0.17%
2,299 $489,000
Q2 2021

Jul 19, 2021

BUY
$233.58 - $259.14 $1,401 - $1,554
6 Added 0.26%
2,295 $559,000
Q1 2021

Apr 29, 2021

BUY
$221.91 - $258.6 $32,842 - $38,272
148 Added 6.91%
2,289 $570,000
Q4 2020

Feb 02, 2021

BUY
$216.38 - $257.67 $217,894 - $259,473
1,007 Added 88.8%
2,141 $492,000
Q4 2019

Jan 29, 2020

SELL
$189.21 - $243.2 $39,166 - $50,342
-207 Reduced 15.44%
1,134 $273,000
Q3 2019

Oct 15, 2019

BUY
$174.11 - $208.62 $233,481 - $279,759
1,341 New
1,341 $259,000
Q1 2019

May 09, 2019

SELL
$180.87 - $203.88 $49,377 - $55,659
-273 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $48,703 - $56,852
273 New
273 $53,000
Q2 2018

Aug 03, 2018

SELL
$166.05 - $186.51 $44,999 - $50,544
-271 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$169.43 - $198.0 $45,915 - $53,658
271 New
271 $46,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $178B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Well Done, LLC Portfolio

Follow Well Done, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Well Done, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Well Done, LLC with notifications on news.